Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1293
Pharmaceutical Excipients Market is estimated to value over CAGR of over 5.1% during the forecast period 2022 to 2028. A pharmaceutical excipient acts as a synthetic or natural substance made with an active ingredient of a medication. It is found in the form of a pharmaceutical dosage to help in the manufacturing operations and it serves to support, protect or even heighten stability. Additionally, they aid in identifying the products and strengthen the safety or functional aspects of the product. The surge in the pharmaceutical excipients market potential can be the result of the expanding pharmaceuticals industry along with innovations in functional excipients, the growing acceptance of orphan drugs, and the rise in the allowance of biopharmaceuticals. However, the high costs, time consumption in the drug development procedure, as well as the stringency enacted by regulatory bodies are factors which may pose hindrances to the market growth during the forecast time frame. By product type, the market for pharmaceutical excipients is classified into three primary categories namely, inorganic chemicals, organic chemicals as well as other chemicals. The organic chemicals was demonstrated to hold the largest market share. The considerable market share is owing to the usage of these chemicals in the numerous pharmaceutical formulations which are accessible in the pharmaceutical market. The diluents & fillers segment has acquired a bulk of the market share of the pharmaceutical excipients industry. The significant market value of this segment is linked to the growing usage of diluents & fillers in the production and development processes of solid oral drugs and the benefits that they provide to patients and manufacturers alike. With the formulation, the pharmaceutical excipients market is divided into topical, oral, parenteral, as well as formulations. Oral formulations has seen robust growth for this market, primarily due to oral formulations being the most common method of drug delivery. Among the key players in the market includes Ashland Global Holdings, Basf Se, DuPont, Roquette Feres, Evonik Industries AG, Associated British Foods, Archer Daniels Midland Company, Lubrizol Corporation, Croda International, Holdings. Pharmaceutical Excipients Market Segmentation: By Product Organic Chemicals Inorganic Chemicals Other Devices By Functionality Fillers & Diluents Suspending & Viscosity Agents Coating Agents Binders Flavoring Agents & Sweeteners Disintegrants Colorants Lubricants & Glidants Preservatives Emulsifying Agents Other Functionalities By Formulation Oral Formulations Topical Formulations Parenteral Formulations Other Formulations By Region Europe North America Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the market by Product, by functionality, by formulation and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record, evaluate and analyze competitive landscape mapping- technological advancements, product launches, expansions and mergers Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
A pharmaceutical excipient acts as a synthetic or natural substance made with an active ingredient of a medication. It is found in the form of a pharmaceutical dosage to help in the manufacturing operations and it serves to support, protect or even heighten stability. Additionally, they aid in identifying the products and strengthen the safety or functional aspects of the product.
The surge in the pharmaceutical excipients market potential can be the result of the expanding pharmaceuticals industry along with innovations in functional excipients, the growing acceptance of orphan drugs, and the rise in the allowance of biopharmaceuticals. However, the high costs, time consumption in the drug development procedure, as well as the stringency enacted by regulatory bodies are factors which may pose hindrances to the market growth during the forecast time frame.
By product type, the market for pharmaceutical excipients is classified into three primary categories namely, inorganic chemicals, organic chemicals as well as other chemicals. The organic chemicals was demonstrated to hold the largest market share. The considerable market share is owing to the usage of these chemicals in the numerous pharmaceutical formulations which are accessible in the pharmaceutical market.
The diluents & fillers segment has acquired a bulk of the market share of the pharmaceutical excipients industry. The significant market value of this segment is linked to the growing usage of diluents & fillers in the production and development processes of solid oral drugs and the benefits that they provide to patients and manufacturers alike.
With the formulation, the pharmaceutical excipients market is divided into topical, oral, parenteral, as well as formulations. Oral formulations has seen robust growth for this market, primarily due to oral formulations being the most common method of drug delivery.
Among the key players in the market includes Ashland Global Holdings, Basf Se, DuPont, Roquette Feres, Evonik Industries AG, Associated British Foods, Archer Daniels Midland Company, Lubrizol Corporation, Croda International, Holdings.
Pharmaceutical Excipients Market Segmentation:
By Product
By Functionality
By Formulation
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Pharmaceutical Excipients Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Pharmaceutical Excipients Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Pharmaceutical Excipients Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Pharmaceutical Excipients Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Pharmaceutical Excipients Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Organic Chemicals 7.2. Inorganic Chemicals 7.3. Other Devices 8. Global Pharmaceutical Excipients Market, By Formulation Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Oral Formulations 8.2. Topical Formulations 8.3. Parenteral Formulations 8.4. Other Formulations 9. Global Pharmaceutical Excipients Market, By Functionality Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Fillers & Diluents 9.2. Suspending & Viscosity Agents 9.3. Coating Agents 9.4. Binders 9.5. Flavoring Agents & Sweeteners 9.6. Disintegrants 9.7. Colorants 9.8. Lubricants & Glidants 9.9. Preservatives 9.10. Emulsifying Agents 9.11. Other Functionalities 10. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Ashland Global Holdings 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. BASF SE 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. DuPont 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Roquette Feres 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Evonik Industries AG 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Associated British Foods 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Archer Daniels Midland Company 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Lubrizol Corporation 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Croda International 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Holdings 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics